Rab Burtun
I qualified as a Nurse in 1988 in Salford Manchester UK . I worked as a Senior Diabetes Nurses Specialist since in Tameside General Hospital, Manchester, UK for 12 yrs with a special interest in Diabetes and Pregnancy. I worked in Trafford Primary Care Trust (UK) as a Diabetes Nurse Facilitator for 3 yrs, my key responsibilities were to educate Practice Nurses, GPs, Pharmacists, selected secondary care Professionals and the general public on issues surrounding Diabetes and its effective management. I am an accredited “Insulin Initiating Trainer” from Warwick University. I am responsible for organising and running workshops on “Initiating Insulin in Primary care” for General Practitioners and Practice Nurses. I emigrating to New Zealand in 2004. I have been working as a Diabetes Nurse Specialist for Waitemata DHB at Waitakere Hospital for the last 7 yrs.
Starting Insulin in Diabetes in Your Practice Concurrent Workshop  Friday, 13 June 2014 Start 2:00pm Duration: 120mins Room 4 Type 2 diabetes management needs on going treatment modifications due to progressive beta cell failure. There is no doubt that optimal glycaemic control reduces or prevents the development of microvascular complications. There are various insulin preparations and regimes available but therapy should be individualised according to patient’s wishes and needs. Insulin initiation in type 2 diabetes should be considered in a timely fashion and expected to be commenced in the primary care due to increased prevalence of type 2 diabetes in the community. After initiation of insulin, ongoing titration/intensification of insulin in a safe manner is a key factor to achieve treatment success which is more and more expected from the primary care. Note: re presentation (only handout provided due to confidentiality) Masterclass in Insulin Management in General Practice Concurrent Workshop Friday, 13 June 2014 Start 4:30pm Duration: 120mins Room 4 Type 2 diabetes management needs on going treatment modifications due to progressive beta cell failure. There is no doubt that optimal glycaemic control reduces or prevents the development of microvascular complications. There are various insulin preparations and regimes available but therapy should be individualised according to patient’s wishes and needs. Insulin initiation in type 2 diabetes should be considered in a timely fashion and expected to be commenced in the primary care due to increased prevalence of type 2 diabetes in the community. After initiation of insulin, ongoing titration/intensification of insulin in a safe manner is a key factor to achieve treatment success which is more and more expected from the primary care.